Nutriband Inc (NTRB) Stock Price, Quote & News - Mboum

Company Profile

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products in the United States. The company's lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. It also develops AVERSA buprenorphine and AVERSA methylphenidate, and other transdermal pharmaceutical products. The company h...

Industry: Biotechnology

Sector: Healthcare

Phone: 407 377 6695

Website: www.nutriband.com

Address:

121 South Orange Avenue, Suite 1500, Orlando, United States

nutriband_com May. 15 at 9:14 PM

$NTRB Nutriband and Active Intelligence will showcase expanding AI wellness and recovery products at the upcoming ECRM Conference. Meetings scheduled with buyers from Walmart, Walgreens, Amazon, Cardinal Health and other major retailers. New launches include AI Energy Patches, AI Sleep and AI Performance Tape. https://www.nutriband.com/post/nutriband-inc-to-showcase-expanding-ai-wellness-product-portfolio-and-new-june-product-launches-at-e #NTRB #healthcare #wellness #retail

0 · Reply

NetworkNewsWire May. 15 at 5:27 PM

BioMedNewsBreaks — $NTRB Subsidiary Active Intelligence to Showcase Wellness Products at ECRM Conference https://ibn.fm/MdpEg

0 · Reply

Acousticstyle May. 14 at 8:17 PM

$NTRB lets see some positive updates on the trial and we can get back to more reasonable share price.

0 · Reply

Acousticstyle May. 14 at 3:57 PM

$NTRB Can we have a nice run like SLS. was in that awhile ago and takes off now the last few days

1 · Reply

birdmanCap May. 14 at 3:46 PM

$NTRB 🔜

0 · Reply

Covode13 May. 14 at 12:01 PM

$NTRB dragging feet

0 · Reply

NVDAMillionaire May. 13 at 8:54 PM

$NTRB Great piece that accurately captures NTRB's current position. So if you want to refresh your understanding of NTRB or learn about NTRB for the first time, this is essential reading. https://everyticker.com/quote/NTRB/analysis/nutriband-s-fda-gauntlet-why-aversa-fentanyl-represents-a-high-risk-high-reward-inflection-point-nasdaq-ntrb

0 · Reply

birdmanCap May. 13 at 2:57 PM

$NTRB Iv been twice with this company when volume dried up extremely thin and both times it popped not long after. Adding some shares here each day while I can

1 · Reply

Covode13 May. 11 at 1:54 PM

$NTRB gave us all these worthless shares

0 · Reply

Covode13 May. 11 at 1:28 PM

$NTRB flat

0 · Reply

Latest News on NTRB

Nutriband Inc to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference

May 15, 2026, 7:00 AM EDT - 15 hours ago

Nutriband Inc to Showcase Expanding AI Wellness Product Portfolio and New June Product Launches at ECRM Conference

Nutriband CEO, Gareth Sheridan Discusses the US Fentanyl Crisis and Company Update on Latest Episode of the Jack Neel Podcast

Apr 22, 2026, 7:00 AM EDT - 23 days ago

Nutriband CEO, Gareth Sheridan Discusses the US Fentanyl Crisis and Company Update on Latest Episode of the Jack Neel Podcast

Mar 30, 2026, 4:05 PM EDT - 6 weeks ago

Nutriband Selects Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch

Nutriband Signs Exclusive Distribution Agreement with Innomedica for AVERSA Fentanyl and all Sports Tape products for Costa Rica

Feb 17, 2026, 7:28 AM EST - 3 months ago

Nutriband Signs Exclusive Distribution Agreement with Innomedica for AVERSA Fentanyl and all Sports Tape products for Costa Rica

Nutriband Inc. provides summary of Annual Shareholder Meeting Key Discussion Points

Jan 30, 2026, 7:00 AM EST - 3 months ago

Nutriband Inc. provides summary of Annual Shareholder Meeting Key Discussion Points

Nutriband CEO Publishes Letter to Shareholders

Dec 31, 2025, 7:00 AM EST - 4 months ago

Nutriband CEO Publishes Letter to Shareholders

Nutriband Inc. Signs Agreement to Sell Majority Stake of Subsidiary Pocono Pharmaceutical for $5M USD to EarthVision Bio

Dec 29, 2025, 9:00 AM EST - 4 months ago

Nutriband Inc. Signs Agreement to Sell Majority Stake of Subsidiary Pocono Pharmaceutical for $5M USD to EarthVision Bio

Nutriband Differentiates Prescription Fentanyl from Illicit Fentanyl in Response to United States Executive Order Designating Fentanyl as a Weapon of Mass Destruction

Dec 18, 2025, 7:00 AM EST - 5 months ago

Nutriband Differentiates Prescription Fentanyl from Illicit Fentanyl in Response to United States Executive Order Designating Fentanyl as a Weapon of Mass Destruction

Nutriband Inc. To Present at The 2025 Noble Capital Markets Emerging Growth Equity Conference

Nov 24, 2025, 7:00 AM EST - 6 months ago

Nutriband Inc. To Present at The 2025 Noble Capital Markets Emerging Growth Equity Conference

REPEAT — Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch

Oct 28, 2025, 11:05 AM EDT - 7 months ago

REPEAT — Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch

Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch

Oct 28, 2025, 7:00 AM EDT - 7 months ago

Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch

Oct 10, 2025, 7:00 AM EDT - 7 months ago

Nutriband Signs Agreement With Brand Institute to Develop the Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch

Nutriband Files Provisional Patent Application for Enhanced Transdermal Abuse Deterrent Technology

Oct 8, 2025, 8:30 AM EDT - 7 months ago

Nutriband Files Provisional Patent Application for Enhanced Transdermal Abuse Deterrent Technology

Nutriband To Present at the Noble Capital Markets' Emerging Growth Virtual Equity Conference

Oct 8, 2025, 6:30 AM EDT - 7 months ago

Nutriband To Present at the Noble Capital Markets' Emerging Growth Virtual Equity Conference

Nutriband Inc. to Present at the MicroCap Rodeo Conference

Sep 24, 2025, 4:05 PM EDT - 8 months ago

Nutriband Inc. to Present at the MicroCap Rodeo Conference

Nutriband Inc. Quarterly Report Highlights Record Revenue for Q2, 2025 up 50.87% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl

Sep 10, 2025, 9:15 AM EDT - 8 months ago

Nutriband Inc. Quarterly Report Highlights Record Revenue for Q2, 2025 up 50.87% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl

Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $5,306,000

Sep 3, 2025, 4:01 PM EDT - 9 months ago

Nutriband Inc. announces exercise of warrants at $6.43 for Gross Proceeds of $5,306,000

Nutriband Inc. to Present on the Emerging Growth Conference on August 20, 2025

Aug 18, 2025, 9:00 AM EDT - 9 months ago

Nutriband Inc. to Present on the Emerging Growth Conference on August 20, 2025

Nutriband CEO Gareth Sheridan Seeks Nomination in Upcoming Irish Presidential Election

Aug 11, 2025, 5:00 AM EDT - 9 months ago

Nutriband CEO Gareth Sheridan Seeks Nomination in Upcoming Irish Presidential Election

FDA Grants Nutriband Meeting Request for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch

Aug 8, 2025, 8:00 AM EDT - 10 months ago

FDA Grants Nutriband Meeting Request for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch

Nutriband Confirms Record and Pay date for 25% Preferred Stock Dividend as it Targets Filing for FDA Approval

Jul 18, 2025, 9:15 AM EDT - 10 months ago

Nutriband Confirms Record and Pay date for 25% Preferred Stock Dividend as it Targets Filing for FDA Approval

Nutriband Announces 25% Preferred Stock Dividend as it targets filing for FDA approval

Jul 2, 2025, 8:05 AM EDT - 11 months ago

Nutriband Announces 25% Preferred Stock Dividend as it targets filing for FDA approval

Nutriband Inc. added to the Russell Microcap® Index, Russell Microcap Growth® Index, Russell 3000E® Index and Russell 3000E Growth® Index

Jul 1, 2025, 7:00 AM EDT - 11 months ago

Nutriband Inc. added to the Russell Microcap® Index, Russell Microcap Growth® Index, Russell 3000E® Index and Russell 3000E Growth® Index

Nutriband Announces U.S. Patent Issued for Its Transdermal Abuse Deterrent Technology

Jun 9, 2025, 7:30 AM EDT - 1 year ago

Nutriband Announces U.S. Patent Issued for Its Transdermal Abuse Deterrent Technology

Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology

Apr 11, 2025, 7:00 AM EDT - 1 year ago

Nutriband Granted Patent in Macao for its AVERSA Abuse Deterrent Transdermal Technology

UPDATE – Nutriband Signs Associate Partnership with Charlotte FC

Apr 4, 2025, 5:41 PM EDT - 1 year ago

UPDATE – Nutriband Signs Associate Partnership with Charlotte FC

Nutriband Signs Partnership Agreement with Charlotte FC

Apr 4, 2025, 7:00 AM EDT - 1 year ago

Nutriband Signs Partnership Agreement with Charlotte FC

Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development.

Feb 21, 2025, 7:00 AM EST - 1 year ago

Nutriband Receives Certificate of Registration for Trademark covering Pharmaceutical and Product Research and Development.

Nutriband and Kindeva Drug Delivery Formalize Exclusive Development Partnership for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch

Feb 13, 2025, 7:00 AM EST - 1 year ago

Nutriband and Kindeva Drug Delivery Formalize Exclusive Development Partnership for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch

Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa™

Feb 7, 2025, 8:45 AM EST - 1 year ago

Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa™

Nutriband Issues Letter to Shareholders

Dec 31, 2024, 7:00 AM EST - 1 year ago

Nutriband Issues Letter to Shareholders

Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology

Dec 27, 2024, 9:25 AM EST - 1 year ago

Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology

Nutriband Inc. Quarterly Report Highlights Record Revenue for Q3 up 50.94% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025

Dec 4, 2024, 9:00 AM EST - 1 year ago

Nutriband Inc. Quarterly Report Highlights Record Revenue for Q3 up 50.94% YOY and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025

Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa™ Abuse Deterrent Transdermal Technology

Nov 27, 2024, 7:00 AM EST - 1 year ago

Nutriband Receives Hong Kong Patent Notice of Publication for Its Aversa™ Abuse Deterrent Transdermal Technology

Nutriband Inc. Issued Full Patent from the Chinese National Intellectual Property Administrant for Its "Abuse and Misuse Deterrent Transdermal System" Application

Oct 31, 2024, 8:35 AM EDT - 1 year ago

Nutriband Inc. Issued Full Patent from the Chinese National Intellectual Property Administrant for Its "Abuse and Misuse Deterrent Transdermal System" Application

Nutriband Inc Mosquito Repellent Patch Approved by Ministry of Health of Costa Rica

Oct 17, 2024, 7:00 AM EDT - 1 year ago

Nutriband Inc Mosquito Repellent Patch Approved by Ministry of Health of Costa Rica

Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on October 17

Oct 2, 2024, 7:00 AM EDT - 1 year ago

Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on October 17

Nutriband Receives China Patent Notice of Allowance for Its Aversa(TM) Abuse Deterrent Transdermal Technology

Sep 24, 2024, 7:00 AM EDT - 1 year ago

Nutriband Receives China Patent Notice of Allowance for Its Aversa(TM) Abuse Deterrent Transdermal Technology

Sep 20, 2024, 6:50 AM EDT - 1 year ago

Nutriband Licenses Bitrex(R) Brand Aversive Agent for Its Lead Product - Aversa(TM) Fentanyl Transdermal Patch

Nutriband Inc. Authorizes $1M Share Buyback Program

Sep 16, 2024, 4:00 PM EDT - 1 year ago

Nutriband Inc. Authorizes $1M Share Buyback Program

Nutriband Inc. Quarterly Report Highlights Strong Cash Position, and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025

Sep 4, 2024, 7:00 AM EDT - 1 year ago

Nutriband Inc. Quarterly Report Highlights Strong Cash Position, and Strategic Progress Toward NDA Filing for AVERSA Fentanyl in 2025

Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on July 25

Jul 19, 2024, 7:00 AM EDT - 1 year ago

Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on July 25

Nutriband Receives Notice of Allowance for U.S. Trademark Covering AVERSA(TM) Abuse Deterrent Technology

Jul 15, 2024, 7:00 AM EDT - 1 year ago

Nutriband Receives Notice of Allowance for U.S. Trademark Covering AVERSA(TM) Abuse Deterrent Technology

Nutriband Provides Product Development Update for Its Lead Product Aversa Fentanyl

Jun 20, 2024, 7:00 AM EDT - 2 years ago

Nutriband Provides Product Development Update for Its Lead Product Aversa Fentanyl

Nutriband Inc. Quarterly Report Emphasizes Focus on Kinesiology Tape Output as Q1 Sports Tape Revenues Increase 219% Year Over Year

Jun 3, 2024, 7:00 AM EDT - 2 years ago

Nutriband Inc. Quarterly Report Emphasizes Focus on Kinesiology Tape Output as Q1 Sports Tape Revenues Increase 219% Year Over Year

Nutriband Appoints Accomplished Business Leader Sergei Glinka to its Board of Directors

May 16, 2024, 7:00 AM EDT - 2 years ago

Nutriband Appoints Accomplished Business Leader Sergei Glinka to its Board of Directors

Can-Fite BioPharma and Nutriband Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

May 10, 2024, 9:00 AM EDT - 2 years ago

Can-Fite BioPharma and Nutriband Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV

Apr 23, 2024, 7:00 AM EDT - 2 years ago

Nutriband Inc. Signs Exclusive Supplier Agreement with Major Sports Brand Licensee Fit for Life Group

Nutriband Inc. Announces $8.4M Private Placement

Apr 19, 2024, 7:00 AM EDT - 2 years ago

Nutriband Inc. Announces $8.4M Private Placement

Nutriband Announces Data Supporting Need for Safer Abuse-Deterrent Transdermal Patches Presented at 2024 American Academy of Pain Medicine Annual Meeting

Mar 25, 2024, 7:00 AM EDT - 2 years ago

Nutriband Announces Data Supporting Need for Safer Abuse-Deterrent Transdermal Patches Presented at 2024 American Academy of Pain Medicine Annual Meeting

nutriband_com May. 15 at 9:14 PM

$NTRB Nutriband and Active Intelligence will showcase expanding AI wellness and recovery products at the upcoming ECRM Conference. Meetings scheduled with buyers from Walmart, Walgreens, Amazon, Cardinal Health and other major retailers. New launches include AI Energy Patches, AI Sleep and AI Performance Tape. https://www.nutriband.com/post/nutriband-inc-to-showcase-expanding-ai-wellness-product-portfolio-and-new-june-product-launches-at-e #NTRB #healthcare #wellness #retail

0 · Reply

NetworkNewsWire May. 15 at 5:27 PM

BioMedNewsBreaks — $NTRB Subsidiary Active Intelligence to Showcase Wellness Products at ECRM Conference https://ibn.fm/MdpEg

0 · Reply

Acousticstyle May. 14 at 8:17 PM

$NTRB lets see some positive updates on the trial and we can get back to more reasonable share price.

0 · Reply

Acousticstyle May. 14 at 3:57 PM

$NTRB Can we have a nice run like SLS. was in that awhile ago and takes off now the last few days

1 · Reply

birdmanCap May. 14 at 3:46 PM

$NTRB 🔜

0 · Reply

Covode13 May. 14 at 12:01 PM

$NTRB dragging feet

0 · Reply

NVDAMillionaire May. 13 at 8:54 PM

$NTRB Great piece that accurately captures NTRB's current position. So if you want to refresh your understanding of NTRB or learn about NTRB for the first time, this is essential reading. https://everyticker.com/quote/NTRB/analysis/nutriband-s-fda-gauntlet-why-aversa-fentanyl-represents-a-high-risk-high-reward-inflection-point-nasdaq-ntrb

0 · Reply

birdmanCap May. 13 at 2:57 PM

$NTRB Iv been twice with this company when volume dried up extremely thin and both times it popped not long after. Adding some shares here each day while I can

1 · Reply

Covode13 May. 11 at 1:54 PM

$NTRB gave us all these worthless shares

0 · Reply

Covode13 May. 11 at 1:28 PM

$NTRB flat

0 · Reply

Acousticstyle May. 8 at 5:49 PM

$NTRB nice buys $3.80

0 · Reply

SuperGreenToday May. 6 at 12:18 PM

0 · Reply

Acousticstyle May. 6 at 12:45 AM

$NTRB like to see this break $5 again

1 · Reply

birdmanCap May. 5 at 6:36 PM

$NTRB good volume spike today

0 · Reply

birdmanCap May. 5 at 3:01 PM

$NTRB 🙌🏻

0 · Reply

Covode13 May. 5 at 1:06 PM

0 · Reply

NNTrader May. 4 at 6:14 PM

$NTRB added here

0 · Reply

BullInvest May. 4 at 4:34 PM

$NTRB whoever holds this deserves the day that it shoots up. I really hope they deliver and get that FDA approval and send this to $20 a share. We have been waiting for so long, missed many other opportunities waiting for it to go up.

1 · Reply

birdmanCap May. 1 at 6:49 PM

0 · Reply

Covode13 Apr. 29 at 12:05 PM

$NTRB Dragging feet and false hopes of FDA approval

1 · Reply

Covode13 Apr. 28 at 12:27 AM

$NTRB starting to feel like trash

0 · Reply

BGfalcons Apr. 27 at 8:17 PM

$NTRB So glad I took my profit a year ago. It has been over 3 years and they keep rehashing the same news what the patch would be worth, blah, blah blah. FDA approval next blah, blah, blah. That was 3 years ago. CEO is blah, blah, blah....

1 · Reply